Wilson Sonsini Goodrich & Rosati advised Lilly Asia Ventures on the deal.Regor Therapeutics, a clinical-stage biotechnology company dedicated to the discovery of innovative medicines to treat…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
